# Bio*One Capital: portfolio, investments and team > Bio*One Capital is a corporate vc based in Singapore. 20 investments on record, latest Oct 2013. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/bio-one-capital (Millionrounds; every figure on the page links to its filing or article) Singapore · [Investor](https://millionrounds.com/investors) # Bio*One Capital Last cheque observed Oct 2013. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet Corporate VC Series D Series B Series C Cheques on record **0%** of best year **0** **cheques in 12 months**, 20 on record Since the last cheque **4766** days **00** hrs **00** min **00** sec Median round **$21M** Rounds led **0 of 20** Exits **5 from the portfolio** Mostly in **United States, 80%** Pitch Bio*One Capital ## Bio*One Capital highlights - 01 20 rounds on record - 02 Mostly Series D and Series B: 42% of its rounds - 03 5 exits from the portfolio ## What they do - **Type:** Corporate VC (from a list, unverified) - **Cheque size:** Not stated - **Based in:** Singapore - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **20 appearances** - **2013** 1 round - **Oct** **[Amaranth Medical](https://millionrounds.com/company/amaranth-medical)** Series B · US · amaranthmedical.com **$20M** With 3 others - **2010** 4 rounds - **Oct** **[MerLion Pharmaceuticals](https://millionrounds.com/company/merlion-pharmaceuticals)** Series C · SG · onbiovc.com **$7.0M** With 2 others - **Oct** **[TriReme Medical](https://millionrounds.com/company/trireme-medical)** Series D · US · prnewswire.com **$17M** With 2 others - **Jul** **[Artisan Pharma](https://millionrounds.com/company/artisan-pharma)** Series C · US · masshightech.com **$3.0M** With 4 others - **Mar** **[Artisan Pharma](https://millionrounds.com/company/artisan-pharma)** Series B · US · artisanpharma.net **$22M** With 3 others - **2009** 3 rounds - **Dec** **[FORMA Therapeutics](https://millionrounds.com/company/forma-therapeutics)** Series B · US · masshightech.com **$3.0M** With 3 others - **Dec** **[FORMA Therapeutics](https://millionrounds.com/company/forma-therapeutics)** Series B · US · altassets.com **$26M** With 3 others - **Oct** **[Inviragen](https://millionrounds.com/company/inviragen)** Series A · US · inviragen.com **$15M** With 3 others - **2008** 1 round - **Oct** **[S*Bio](https://millionrounds.com/company/s-bio)** Venture · SG **$26M** With 5 others - **2007** 3 rounds - **Dec** **[Pelikan Technologies](https://millionrounds.com/company/pelikan-technologies)** Series F · US · venturebeat.com **$69M** With 2 others - **Jan** **[Fluidigm](https://millionrounds.com/company/fluidigm)** Series E · US · deals.venturebeat.com **$17M** With 9 others - **Jan** **[Fluidigm](https://millionrounds.com/company/fluidigm)** Series E · US **$37M** With 7 others - **2006** 4 rounds - **Sept** **[RenaMed Biologics](https://millionrounds.com/company/renamed-biologics)** Venture · US · venturecapitalreporter.com **$40M** With 8 others - **Sept** **[Artisan Pharma](https://millionrounds.com/company/artisan-pharma)** Series A · US · artisanpharma.net **$39M** With 4 others - **Aug** **[Codexis](https://millionrounds.com/company/codexis)** Series D · US · codexis.com **$37M** With 4 others - **Jul** **[Takeda Cambridge](https://millionrounds.com/company/takeda-cambridge)** Series D · GB **$13M** With 2 others - **2005** 1 round - **Jan** **[Takeda Cambridge](https://millionrounds.com/company/takeda-cambridge)** Venture · GB **$9.4M** With 2 others - **2004** 2 rounds - **May** **[Microbia](https://millionrounds.com/company/microbia)** Series D · US **$40M** With 3 others - **Feb** **[Kadmus Pharmaceuticals](https://millionrounds.com/company/kadmus-pharmaceuticals)** Series A · US **$15M** With 6 others - **2003** 1 round - **Jan** **[Raven Biotechnologies](https://millionrounds.com/company/raven-biotechnologies)** Series C · US **$40M** With 8 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## Exits from the portfolio Companies it backed that were later bought or listed **5 in all** **[Inviragen](https://millionrounds.com/company/inviragen)** Bought by [Takeda Pharmaceutical](https://millionrounds.com/fund/takeda-pharmaceutical) **Undisclosed** May 2013 **[Artisan Pharma](https://millionrounds.com/company/artisan-pharma)** Bought by Asahi Kasei Pharma **Undisclosed** Nov 2011 **[Microbia](https://millionrounds.com/company/microbia)** Bought by DSM **Undisclosed** Sept 2010 **[Codexis](https://millionrounds.com/company/codexis)** Listed **Undisclosed** Apr 2010 **[Raven Biotechnologies](https://millionrounds.com/company/raven-biotechnologies)** Bought by MacroGenics **Undisclosed** Jul 2008 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Series D Series B Series C Median round joined **$21M** the round, not its cheque Led 0 of 20 rounds **0%** - **Sole investor:** Never alone - **Last cheque:** Oct 2013 - **Exits:** 5 from the portfolio Rounds by stage said on their site - Series D *4* - Series B *4* - Series C *3* - Series A *3* - Venture *3* - Series E *2* Cheques by year Led Joined 2003 2013 Often in the room with - [Jafco Ventures](https://millionrounds.com/fund/jafco-ventures) 3 - [Lilly Ventures](https://millionrounds.com/fund/lilly-ventures) 3 - [NGN Capital](https://millionrounds.com/fund/ngn-capital) 3 - [Alloy Ventures](https://millionrounds.com/fund/alloy-ventures) 2 - [Aravis Ventures](https://millionrounds.com/fund/aravis-sa) 2 - [Avlar BioVentures](https://millionrounds.com/fund/avlar-bioventures) 2 **Pitching Bio*One Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Bio*One Capital. A count of rooms they were both in, not a relationship either has claimed. [**Jafco Ventures** Growth equity **3** rounds together](https://millionrounds.com/fund/jafco-ventures)[**Lilly Ventures** Corporate VC **3** rounds together](https://millionrounds.com/fund/lilly-ventures)[**NGN Capital** VC firm **3** rounds together](https://millionrounds.com/fund/ngn-capital)[**Alloy Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/alloy-ventures)[**Aravis Ventures** Private equity **2** rounds together](https://millionrounds.com/fund/aravis-sa)[**Avlar BioVentures** Investment firm **2** rounds together](https://millionrounds.com/fund/avlar-bioventures)[**CMEA Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/cmea-capital)[**Charter Life Sciences** VC firm **2** rounds together](https://millionrounds.com/fund/charter-life-sciences)[**EuclidSR Partners** Growth equity **2** rounds together](https://millionrounds.com/fund/euclidsr-partners)[**InterWest Partners** VC firm **2** rounds together](https://millionrounds.com/fund/interwest-partners)[**Merlin Biosciences** Growth equity **2** rounds together](https://millionrounds.com/fund/merlin-biosciences)[**New Leaf Venture Partners** VC firm **2** rounds together](https://millionrounds.com/fund/new-leaf-venture-partners) ## Quick answers about Bio*One Capital ### What does Bio*One Capital invest in? Bio*One Capital invests most often at Series D and Series B (42% of the rounds on record). ### How active is Bio*One Capital? 20 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2013. ### How big are Bio*One Capital's cheques? The median round it joins is $21M. ### Does Bio*One Capital lead rounds? Rarely, if at all: none of its 20 investments on record names it as the lead. ### Where does Bio*One Capital invest? Most of the companies it backs are in the United States (80%), Singapore (10%) and the United Kingdom (10%). ### Is Bio*One Capital investing now? No investments in the last 12 months; the latest was in Oct 2013. ### Who does Bio*One Capital invest alongside? Most often Jafco Ventures (3 rounds together), Lilly Ventures (3 rounds together) and NGN Capital (3 rounds together). ### What kind of investor is Bio*One Capital? Bio*One Capital is a corporate VC based in Singapore. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=bio-one-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=bio-one-capital)